Companies Dominating the Microneedle Drug Delivery Systems Landscape
- ICU Medical Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Becton, Dickinson, and Company
- B. Braun Medical Inc.
- NanoPass Technologies Ltd
- Thermo Fisher Scientific
- Cardinal Health, Inc.
- 3M
- TheraJect, Inc.
- Siemens Healthcare GmbH
- Raphas Co., Ltd.
- Daewoong Pharmaceutical
- Revive Therapeutics Ltd.
The dermatology category is becoming a prime focus for key players in the market. They are continuously evolving the method and components of their offerings to make treatment more effective and durable. For instance, in February 2023, Candela introduced a multi-application system, Profound Matrix, featuring the Sublime, Sublative RF, and Matrix Pro applicators. This FDA-approved microneedling device is designed to deliver bipolar radiofrequency treatments and to regenerate & build new collagen to correct, maintain, and restore skin at various stages of aging. Furthermore, several MedTech pioneers are also conducting rigorous studies to establish new applications of their pipelines. Such key players are:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Currently in 2025, the industry revenue of microneedle drug delivery systems is assessed at USD 855.12 million.
The global microneedle drug delivery systems market is projected to increase from USD 812.47 million in 2024 to USD 2.08 billion by 2037, exhibiting a CAGR of over 7.5% during the forecast period, between 2025 and 2037.
North America industry is expected to account for largest revenue share of 36% by 2037, owing to rise in the adoption of highly advanced processes and systems for the manufacture of microneedles and the technical improvements made in microneedle drug delivery.
The major players in the market include ICU Medical Inc., Becton, Dickinson, and Company, B. Braun Medical Inc., NanoPass Technologies Ltd, Thermo Fisher Scientific, Cardinal Health, Inc., 3M, TheraJect, Inc., Siemens Healthcare GmbH, Raphas Co., Ltd.
